CVA Family Office LLC Boosts Stock Position in Zoetis Inc. (NYSE:ZTS)

CVA Family Office LLC boosted its stake in shares of Zoetis Inc. (NYSE:ZTS) by 13.5% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,191 shares of the company’s stock after acquiring an additional 142 shares during the quarter. CVA Family Office LLC’s holdings in Zoetis were worth $206,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. Blue Bell Private Wealth Management LLC boosted its holdings in Zoetis by 222.5% during the 4th quarter. Blue Bell Private Wealth Management LLC now owns 129 shares of the company’s stock valued at $25,000 after acquiring an additional 89 shares during the period. Webster Bank N. A. boosted its holdings in Zoetis by 89.1% during the 1st quarter. Webster Bank N. A. now owns 174 shares of the company’s stock valued at $29,000 after acquiring an additional 82 shares during the period. Private Wealth Management Group LLC purchased a new stake in Zoetis during the 4th quarter valued at about $33,000. Gladius Capital Management LP purchased a new stake in Zoetis during the 4th quarter valued at about $40,000. Finally, Neo Ivy Capital Management purchased a new stake in Zoetis during the 4th quarter valued at about $40,000. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. Piper Sandler reaffirmed an “overweight” rating and set a $195.00 price target (down previously from $220.00) on shares of Zoetis in a research report on Tuesday, April 16th. The Goldman Sachs Group lowered their price target on Zoetis from $223.00 to $196.00 and set a “buy” rating for the company in a research report on Monday, May 6th. BTIG Research initiated coverage on Zoetis in a research report on Thursday, July 25th. They issued a “buy” rating and a $220.00 target price for the company. Stifel Nicolaus raised their target price on Zoetis from $180.00 to $200.00 and gave the company a “buy” rating in a research note on Monday. Finally, Barclays lowered their target price on Zoetis from $260.00 to $230.00 and set an “overweight” rating for the company in a research note on Tuesday, April 23rd. Nine research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Zoetis currently has a consensus rating of “Buy” and a consensus target price of $214.89.

Zoetis Stock Down 0.2 %

NYSE:ZTS traded down $0.39 during trading hours on Wednesday, reaching $184.90. 2,097,111 shares of the company traded hands, compared to its average volume of 2,803,766. The stock has a market capitalization of $84.37 billion, a P/E ratio of 35.70, a P/E/G ratio of 2.80 and a beta of 0.86. The business’s 50-day moving average price is $175.81 and its two-hundred day moving average price is $175.36. Zoetis Inc. has a 1 year low of $144.80 and a 1 year high of $201.92. The company has a current ratio of 3.33, a quick ratio of 1.94 and a debt-to-equity ratio of 1.30.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, August 6th. The company reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.49 by $0.07. The business had revenue of $2.36 billion during the quarter, compared to analyst estimates of $2.31 billion. Zoetis had a return on equity of 50.34% and a net margin of 27.38%. The company’s quarterly revenue was up 8.3% compared to the same quarter last year. During the same quarter last year, the company earned $1.41 EPS. Analysts predict that Zoetis Inc. will post 5.76 earnings per share for the current year.

Zoetis Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 4th. Investors of record on Thursday, July 18th will be issued a $0.432 dividend. This represents a $1.73 annualized dividend and a dividend yield of 0.93%. The ex-dividend date of this dividend is Thursday, July 18th. Zoetis’s payout ratio is currently 33.33%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.